Despite numerous FDA-approved treatment and diagnostic approaches, cancer is one of the
leading causes of death worldwide due to delayed diagnostics and the limited efficacy of …

Anticancer drugs in monotherapy are ineffective to treat various kinds of cancer due to the
heterogeneous nature of cancer. Moreover, available anticancer drugs possessed various …

Increasing evidence suggests that intratumoral microbiota plays a pivotal role in tumor
progression, immunosurveillance, metastasis, and chemosensitivity. Particularly, in …

Simultaneous diagnostics and targeted therapy provide a theranostic approach, an
instrument of personalized medicine—one of the most-promising trends in current medicine …

A supramolecular redox responsive nanogel (NG) with the ability to sense cancer cells and
loaded with a releasing therapeutic agent was synthesized using hostguest interactions …

Radiotherapy (RT) is one of the important tools for clinical treatment of breast cancer.
Currently, some nanoradiosensitizers have been developed for augmenting the therapeutic …

The combination of photothermal and magnetic functionalities in one biocompatible
nanoformulation forms an attractive basis for developing multifunctional agents for …

Glioblastoma (GBM) is the most common malignant brain tumor. Although current treatment
strategies, including surgery, chemotherapy, and radiotherapy, have achieved clinical …

Epigenetic dysregulation is a key factor leading to oncogenesis and tumor progression 1. To
date, seven agents in three epigenetic target classes have been approved by the US Food …

Nanotechnology has been commonly used in a variety of applications in recent years.
Nanomedicine has also gotten a lot of attention in the medical and treatment fields …